$CAMP 8-K SEC Filings

Filed On	Filing
28 Sep 2026	8-K: Regulation FD Disclosure; Other Events On September 28, 2026, CAMP4 Therapeutics Corporation (the “Company”) held an Analyst Day meeting regarding its planned Phase 1/2 ASCEND clinical trial of CMP-002 in SYNGAP1-related disorder (the “ASCEND clinical trial”) and its pipeline...
13 Aug 2026	8-K: Results of Operations and Financial Condition
04 Aug 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
27 Jul 2026	8-K: Regulation FD Disclosure; Other Events
12 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
14 May 2026	8-K: Regulation FD Disclosure
07 May 2026	8-K: Results of Operations and Financial Condition
24 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
05 Mar 2026	8-K: Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure
09 Jan 2026	8-K: Regulation FD Disclosure
23 Dec 2025	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement
18 Dec 2025	8-K: Entry into a Material Definitive Agreement
18 Dec 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
06 Nov 2025	8-K: Results of Operations and Financial Condition
01 Oct 2025	8-K: Regulation FD Disclosure
10 Sep 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
14 Aug 2025	8-K: Results of Operations and Financial Condition
13 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
16 May 2025	8-K: Regulation FD Disclosure
13 May 2025	8-K: Results of Operations and Financial Condition

Comments